Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
To subscribe to The Bloodline with LLS, click here.
My ALL Diagnosis: Alan’s Story
Listen in as Alicia and Lizette speak with Alan Kraimer. Alan is an acute lymphoblastic leukemia (ALL) survivor who owns a small medical supply distribution company in Georgia. In 2014, what Alan and doctors believed to be strep throat soon proved to be otherwise. It was not until his third visit to Urgent Care that he was referred to a hematologist in which he received his leukemia diagnosis. Join Alan, Alicia and Lizette as Alan shares how he was diagnosed, questions he had for his healthcare team, the important role his wife played as his caregiver, and how he learned about an interesting new treatment for his dry eyes called autologous serum drops.
Support for this episode provided by Takeda Oncology.
My MCL Diagnosis: Stan’s Story
Listen in as Alicia and Lizette speak with Stan Friedman. Stan is a trial lawyer and mantle cell lymphoma (MCL) survivor from Savannah, Georgia. After receiving abnormal lab work and noticing swollen lymph nodes that his doctor pointed out, Stan was referred to a hematologist/oncologist for a bone marrow biopsy. Join them as Stan describes how he was diagnosed, the initial questions he asked his healthcare team, side effects that were both common and uncommon, the importance of support from those around him, and how he is doing five years later.
Support for this episode provided by AstraZeneca.
How CAR T-cell Therapy Saved My Life: Chuck’s Story
On this episode, Alicia and Lizette speak with Chuck Colletti, a two-time survivor of Stage 4 follicular lymphoma. Chuck was diagnosed in early 2016 when he underwent 7 months of chemotherapy which put his cancer into temporary remission. Unfortunately, 7 months later, it returned in a more aggressive form. With options dwindling, he was accepted into a CAR T-cell therapy clinical trial. Listen in as he describes how this therapy impacted his life both emotionally and physically, the side effects he experienced and the hope he has in this therapy’s ability to save many more lives.
Support for this episode provided by Celgene; Kite, A Gilead Company; and Novartis Oncology.
Support for The Bloodline with LLS provided by Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene, Jazz Pharmaceuticals; Kite, A Gilead Company; Novartis; Pharmacyclics, an AbbVie company and Janssen Biotech; Seattle Genetics and Takeda Oncology.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.
To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.